Nature Communications (Jan 2024)

Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma

  • Tirtha Chanda,
  • Katja Hauser,
  • Sarah Hobelsberger,
  • Tabea-Clara Bucher,
  • Carina Nogueira Garcia,
  • Christoph Wies,
  • Harald Kittler,
  • Philipp Tschandl,
  • Cristian Navarrete-Dechent,
  • Sebastian Podlipnik,
  • Emmanouil Chousakos,
  • Iva Crnaric,
  • Jovana Majstorovic,
  • Linda Alhajwan,
  • Tanya Foreman,
  • Sandra Peternel,
  • Sergei Sarap,
  • İrem Özdemir,
  • Raymond L. Barnhill,
  • Mar Llamas-Velasco,
  • Gabriela Poch,
  • Sören Korsing,
  • Wiebke Sondermann,
  • Frank Friedrich Gellrich,
  • Markus V. Heppt,
  • Michael Erdmann,
  • Sebastian Haferkamp,
  • Konstantin Drexler,
  • Matthias Goebeler,
  • Bastian Schilling,
  • Jochen S. Utikal,
  • Kamran Ghoreschi,
  • Stefan Fröhling,
  • Eva Krieghoff-Henning,
  • Reader Study Consortium,
  • Titus J. Brinker

DOI
https://doi.org/10.1038/s41467-023-43095-4
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Artificial intelligence (AI) systems have been shown to help dermatologists diagnose melanoma more accurately, however they lack transparency, hindering user acceptance. Explainable AI (XAI) methods can help to increase transparency, yet often lack precise, domain-specific explanations. Moreover, the impact of XAI methods on dermatologists’ decisions has not yet been evaluated. Building upon previous research, we introduce an XAI system that provides precise and domain-specific explanations alongside its differential diagnoses of melanomas and nevi. Through a three-phase study, we assess its impact on dermatologists’ diagnostic accuracy, diagnostic confidence, and trust in the XAI-support. Our results show strong alignment between XAI and dermatologist explanations. We also show that dermatologists’ confidence in their diagnoses, and their trust in the support system significantly increase with XAI compared to conventional AI. This study highlights dermatologists’ willingness to adopt such XAI systems, promoting future use in the clinic.